Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05464251 · ClinicalTrials.gov registry record
Prospective Analysis of Spinal Epidural Abscess
A clinical trial of Spinal Epidural Abscess, sponsored by Francis Farhadi.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05464251: Recruiting study of Spinal Epidural Abscess, sponsored by Francis Farhadi.
NCT05464251 is a study of Spinal Epidural Abscess that is actively recruiting participants, run by Francis Farhadi. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05464251, a study of Spinal Epidural Abscess, is actively recruiting participants, sponsored by Francis Farhadi.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study all available clinical, pathological, radiological, and socioeconomic data of patients diagnosed with a spinal infection with or without a history of drug abuse over this study period. All patients' charts will be prospectively reviewed starting at the time of presentation for a period of 1 year.
Primary Outcome
Determine the statistical correlation between employment status and infection reoccurrence within 1 year of diagnosis.
Conditions Studied
Interventions
- OTHER Prospective chart review of subjects diagnosed with spinal epidural abscess
Study Locations (1)
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-07-12 |
| Est. Completion | 2027-06 |
What NCT05464251 shows while recruiting
NCT05464251 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Spinal Epidural Abscess appearing as the primary indexed condition, and to 1 intervention - of which Prospective chart review of subjects diagnosed with spinal epidural abscess is the first listed.
NCT05464251 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05464251 about?
NCT05464251 is a clinical study titled "Prospective Analysis of Spinal Epidural Abscess". This is a prospective study involving all patients treated at the University of Kentucky for spinal epidural abscess over a 2-year period. Based on ongoing referrals of patients with SEA, we expect that 200 patients will be enrolled during this time window. We propose to study all available clinical...
What is the current status of trial NCT05464251?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2022-07-12. Estimated completion is 2027-06.
What conditions does trial NCT05464251 study?
This clinical trial studies the following conditions: Spinal Epidural Abscess.
What interventions are being tested in trial NCT05464251?
The interventions under investigation include: Prospective chart review of subjects diagnosed with spinal epidural abscess (OTHER).
Who is sponsoring clinical trial NCT05464251?
This trial is sponsored by Francis Farhadi, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05464251 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI